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| INTRODUCTION
The germ cell lineage transmits genetic and epigenetic information to the following generations. Primordial germ cells (PGCs), the early embryonic precursors of the germ cell lineage, differentiate into oocytes in females or sperm in males. To ensure that the appropriate epigenetic information is transmitted across generations, PGCs undergo extensive epigenetic modifications, including chromatin modifications and global erasure of DNA methylation. These complex changes are essential for the formation of healthy gametes. Understanding the mechanisms of the germ cell lineage development is crucial in reproductive medicine for the development of therapies and to treat fertility problems in humans. It is also critical in understanding animal reproduction in order to sustain healthy and high-quality livestock.
A thorough understanding of germ cell lineage development also might contribute to the preservation of endangered species for future generations.
In this review, the research that is studying PGC development in vivo in the mouse is discussed, as well as the successful attempts to derive PGCs from pluripotent stem cells, which also give rise to sperm or eggs in vitro. The recent progress made in studying PGCs in vivo in human is noted, as well as in establishing in vitro human models.
Finally, reports about PGC development in domestic species, such as pig and bovine, are discussed.
| PRIMORDIAL GERM CELL DEVELOPMENT IN VIVO IN THE MOUSE
The mouse is the best-studied research model for investigating the mammalian germ cell lineage. It has been established in gene knockout mice that the PGCs are induced from a competent epiblast by bone morphogenetic protein (BMP) and WNT3 signaling pathways. [1] [2] [3] [4] Early embryonic development, leading to PGC induction, is described in Figure 1 . After fertilization, the mouse zygotes undergo a series of cell divisions that lead to the formation of blastocysts at embryonic day 3.5 (E3.5). The blastocysts are composed of the pluripotent inner cell mass (ICM) and an outer monolayer of differentiated trophectoderm cells. Later, the ICM separates into a pluripotent epiblast and the differentiated primitive endoderm. At ~E4.5, the mouse blastocyst implants to the uterine wall. After implantation, at E5.5, the mouse embryo is rapidly developed and consists of extraembryonic ectoderm (ExE) that is derived from the trophectoderm, visceral endoderm (VE) that is derived from the primitive endoderm, and the epiblast. At this stage, WNT3 is first secreted by the posterior VE and is followed by WNT3 secretion by the posterior epiblast at E5.75. The WNT3 mutants have defects in gastrulation and the mutant epiblast does not form PGCs. also promotes TFAP2C expression. 13, 14 The BLIMP1, PRDM14, and TFAP2C have a crucial role in PGC induction. The BLIMP1 inhibits DNA methylation in the induced genes and somatic cell genes together with TFAP2C. In contrast, PRDM14 promotes germ-cell specific and pluripotency-related genes with TFAP2C. 15 The BLIMP1 acts on the inhibition of target genes and PRDM14 acts on the activation of target genes. It was revealed that NANOG induces BLIMP1 expression independently with the WNT3 or BMP4 signaling pathway. 16 The activation of BLIMP1 by NANOG is inhibited by SOX2, which prohibits F I G U R E 1 Specification of primordial germ cells (PGCs) in vivo in the mouse. At gastrulation, embryonic day 6.5 (E6.5), the mouse embryo forms an egg cylinder with anterior-posterior (A-P) axes. Both bone morphogenetic protein 4 (BMP4) from the extraembryonic ectoderm (ExE) and WNT3 from the posterior visceral endoderm (VE) induced few PGCs. Cerberus 1 (CER1), an antagonist of BMP4, and dickkopf1 (DKK1), an antagonist of WNT3, prevent the PGCs' induction at the anterior epiblast. ICM, inner cell mass; PE, primitive endoderm; TE, trophectoderm embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) from differentiation into PGCs.
| INDUCTION OF PRIMORDIAL GERM CELL-LIKE CELLS IN VITRO IN THE MOUSE
There 
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In initial attempts, the ESCs have been used for the derivation of PGCs through embryoid body formation; [19] [20] [21] [22] however, the efficiency of PGC induction was low, even when BMP4 was added to the cultures. 21 Later, EpiSCs were used for the derivation of PGC-like cells (PGCLCs) in vitro. It was assumed that the EpiSCs are an in vitro equivalent of the epiblast, from which PGCs are specified. However, in the studied EpiSC colonies, <1.5% of the BLIMP1-positive cells also co-expressed Stella, a PGC-specific gene marker. 23 This experiment determined that EpiSCs are not sufficient to generate PGCLCs in vitro.
A two-step approach has been developed to induce PGCLCs from ESCs ( Figure 2 ). 24 In the first step, the ESCs are cultured in the presence of basic fibroblast growth factor (bFGF) and activin
A for 48 hours, thus converting them into EpiSC-like cells (EpiLCs).
Both bFGF and activin A are used for the maintenance of EpiSCs in vitro. In the second step, between 800 and 2000 EpiLCs are cultured in the presence of leukemia inhibitory factor (LIF), stem cell factor (SCF), epidermal growth factor (EGF), and BMP4 for 4-6 days. In these conditions, the EpiLCs form aggregates within which a robust induction of PGCLCs has been observed. The efficiency of PGCLC induction was 30% higher than that observed in the EpiSCs. 23 Moreover, a transcriptome analysis confirmed that in vitro-generated PGCLCs are comparable to in vivo PGCs. This work suggests that PGCLC induction probably occurred during the transition from ESCs to EpiSCs.
In another method, PGCLCs were induced by the overexpression of master genes that are involved in the PGC specification. The overexpression of Blimp1, Tfap2c, and Prdm14 in the EpiLCs generated the PGCLCs efficiently when only Prdm14 was overexpressed. 16, 24 Moreover, it was shown that there was an overexpression of NANOG alone in the EpiLC-induced PGCLCs, even without the presence of BMP4.
25

| DIFFERENTIATION OF THE PRIMORDIAL GERM CELL-LIKE CELLS INTO SPERM AND EGGS IN VITRO
The PGCLCs exhibit transcriptome (expression of pluripotency and germ-cell specific genes) and epigenetic properties (chromatin and DNA modifications) that are associated with the migrating PGCs in the mouse embryo. Therefore, the ability of mouse PGCLCs to differentiate further into sperm or oocytes has been studied in both males and females by many researchers (Figure 2 ). For the reconstruction of oogenesis in vitro, several approaches have been reported. In one method, the reconstructed ovaries were made of female PGCLCs that were mixed with female gonadal somatic cells that had been depleted of PGCs and were implanted into the recipient ovaries. 28 After 4 weeks, the secondary oocytes were isolated from the reconstructed ovaries and fertilized with wild-type sperm to produce viable offspring. However, the efficiency of this approach was very low (3.9%) due to the failure of the PGCLC-derived oocytes and zygotes to extrude the second polar body.
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Recently, an improvement of the previous approach has been reported. 11, 29 The reconstructed ovaries were cultured in the presence of an estrogen inhibitor in order to prevent multi-oocyte formations in one follicle. 13 After 21 days of culture, granulosa cells were detected around the primary oocytes that had developed from the PGCLCs. This was followed by mechanical separation of the sec- 
| INDUCTION OF HUMAN PRIMORDIAL GERM CELL-LIKE CELLS IN VITRO
The progress that has been made by studying mouse PGC development, both in vivo and in vitro, has led researchers to attempt to induce human PGC-like cells (hPGCLCs) from PSCs. Studies on hPGCs are difficult due to the inaccessibility of human embryos for research studies. Therefore, the accurate timing of hPGC specification cannot be determined precisely, but it is assumed to occur at around gastrulation in the second or third week of development. 30 In human, specified PGCs first were identified by displaying their characteristic morphology by using transmission electron microscopy.
The hPGCs were observed in the endoderm of the yolk sac wall near the allantois during the fourth week, or embryonic day 24 (E24). By the sixth week (E37), they migrate through the embryo into the genital ridges, embryonic precursors of the testes or ovaries. During the migration and colonization of the genital ridges, the hPGCs proliferate until the tenth week, when they enter either mitotic quiescence in the XY embryos or meiotic prophase in the XX embryos. was used as a template for inducing hPGCLCs. However, the achieved efficiency of hPGCLC induction from hiPSCs is <5% and from EpiLCs ~30%. [45] [46] [47] It was assumed that the low level of efficiency was a result of the prime state of human ESCs or iPSCs. Therefore, a new protocol was developed, in which hESCs were converted into a naïve form by exposing them to "4i" inhibitors. 
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In an alternative approach, human ESCs or iPSCs first are converted into incipient mesoderm-like cells (iMeLCs) by an exposure to activin A and GSK-3β inhibitor. 49 This is followed by culturing iMeLCs in the presence of BMP4, LIF, SCF, and EGF in a low-adhesion culture for 4 days. The formed aggregates comprise ~30% of the BLIMP1-and TFAP2C-positive hPGCLCs. The in vitro-generated hPGCLCs, using the two protocols described above, are transcriptionally similar 49 and they do not express DDX4 and DAZL, markers of late PGCs in vivo.
It is important to highlight that the comparison between mouse and human PGCLCs showed that PGC specification in the mouse and human differ. In the mouse, BLIMP1 is the master gene to in- 
| INDUCTION OF PRIMORDIAL GERM CELL-LIKE CELLS IN NON-MURINE MAMMALS
The early stages of porcine PGC (pPGC) development appears to be similar to that of the mouse. The PGCs are identified in E12-E14 embryos by OCT4, BLIMP1, and SOX17 expression, pluripotency markers of PGCs. [53] [54] [55] Then, the pPGCs at E15, stage-equivalent to the E8.5
in the mouse, commence migration towards the genital ridges and, at E18, they start to colonize the genital ridges. 56 Recently, the induc- Bovine PGCs are identified by AP staining in E18-E39 old embryos. 58, 59 The AP-positive PGCs are observed in the proximal yolk sac, in the hindgut and midgut, and in the genital ridges. 58, 59 Recently, bovine iPSC lines have been derived. [60] [61] [62] [63] [64] [65] When the bovine iPSCs are converted into a naïve state of pluripotency, they contribute many tissues in the chimera, including gonads. 62 Bovine-primed iPSCs have been induced into bovine PGCLCs (bPGCLCs) via embryoid body formation and culture in the presence of RA and BMP4. 66 However, this approach to induce bPGCLCs is ineffective and is based on the detection of DDX4.
| CONCLUSION
The mouse is the best-studied model of PGC development. This in vitro approach also might help to understand the differences in the development and differentiation of germ cell lineage among a variety of species, including domestic animals and endangered species.
F I G U R E 4
In vitro induction of germ cells in the pig. Naïve-like induced pluripotent stem cells (iPSCs) are cultured in the presence of basic fibroblast growth factor (bFGF) and Actin A, giving rise to epiblast-like cells (EpiLCs), which are exposed to bone morphogenetic protein (BMP)4, leukaemia inhibitory factor (LIF), stem cell factor (SCF), and epidermal growth factor (EGF) and differentiate into primordial germ cell-like cells (PGCLCs). These then differentiate further into spermatogonial stem cell-like cells (SSCLCs) by culturing them with testosterone, retinoic acid (RA), and glial cell line-derived neurotrophic factor (GDNF)
